Перейти к содержанию

Лекарственные взаимодействия

Daunorubicin + Trastuzumab deruxtecan

Тяжесть: Тяжёлое

Daunorubicin and Trastuzumab deruxtecan: major interaction.

Последнее обновление

Для специалистов здравоохранения — только для справки. Эта страница — краткая сводка, а не медицинская консультация и не замена официальной инструкции или клинического суждения. Всегда проверяйте перед назначением или отпуском.

Клиническое содержание этой страницы доступно только на английском языке.

Кратко

Anthracyclines and HER2-directed antibodies both carry cardiotoxicity risk, and giving them together or in close sequence increases the risk of cardiomyopathy and reduced ejection fraction. Trastuzumab deruxtecan also causes interstitial lung disease and myelosuppression.

Что означает это взаимодействие простыми словами

Daunorubicin and Trastuzumab deruxtecan can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Daunorubicin belongs to Oncology; Trastuzumab deruxtecan belongs to Oncology.

Уровень доказательности: High

Почему это происходит

Additive cardiotoxicity from anthracycline myocardial injury and HER2 pathway inhibition in cardiomyocytes.

Что делать

Avoid concurrent use and keep the interval between anthracycline and HER2-directed therapy as long as possible. Assess left ventricular ejection fraction before and regularly during treatment.

О чём спросить фармацевта

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Для подписчиков Pro+

Откройте страницу целиком

Создайте аккаунт и начните пробный период Pro+, чтобы открыть полные рекомендации по ведению для Daunorubicin и Trastuzumab deruxtecan, дополнительные примечания, подробности о доказательной базе и проверку взаимодействий для всего рецепта.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Pro+ бесплатно 14 дней на сайте. Карта не нужна.

Частые вопросы

Can I take Daunorubicin with Trastuzumab deruxtecan?

MediHelp rates the interaction as major. Daunorubicin and Trastuzumab deruxtecan can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Anthracyclines and HER2-directed antibodies both carry cardiotoxicity risk, and giving them together or in close sequence increases the risk of cardiomyopathy and reduced ejection fraction. Trastuzumab deruxtecan also causes interstitial lung disease and myelosuppression.

How serious is the interaction between Daunorubicin and Trastuzumab deruxtecan?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use and keep the interval between anthracycline and HER2-directed therapy as long as possible. Assess left ventricular ejection fraction before and regularly during treatment.

What other medicines interact with Daunorubicin?

MediHelp also lists interactions of Daunorubicin with, for example, Adenovirus types 4 and 7 live, Belatacept, Cyclosporine. The full list is on the Daunorubicin page.

Полные монографии, дозировки и проверка взаимодействий в приложении MediHelp

Откройте полный справочник, проверяйте взаимодействия нескольких препаратов и пользуйтесь инструментами дозирования в приложении MediHelp.

Обзор от A до Z · Лекарственные взаимодействия

Скачать приложение Войти